Think Therapeutics, INC.
At a glance
EmployeesNot reported
In business sinceNot reported
HeadquartersNewton, MA
US patents13
SAM.gov UEIG18KSS1LXQ71
CAGE code8T9J6
Incorporated inDE
- machine learning
Named on the company’s own website, read JUL 29, 2026
Supplier designations
For Profit Organization
Self-certified by the company in its SAM.gov registration
Patents
13 US patents granted 2021–2025, 13 of them in the five years to SEP 2025.
Pharmaceuticals 12Biotechnology 1
- Immunogenic compositions comprising nucleic acids for RAS peptides and their use for treating cancerUS 12,364,741 · granted JUL 22, 2025
- Compositions for optimized BCR-ABL peptide vaccinesUS 12,290,554 · granted MAY 6, 2025
- Method of compact peptide vaccines using residue optimizationUS 12,091,443 · granted SEP 17, 2024
- Compositions and method for optimized peptide vaccines using residue optimizationUS 12,064,475 · granted AUG 20, 2024
- Method of compact peptide vaccines using residue optimizationUS 11,673,936 · granted JUN 13, 2023
Newest 5 shown · Granted to Think Therapeutics, Inc. · PatentsView (USPTO), data through SEP 30, 2025 · CC BY 4.0
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Think Therapeutics, INC. | Newton | MA | — | ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.